Retatrutide balances incretin and glucagon signaling to boost energy expenditure and fat oxidation, achieving 17%+ weight loss in phase 2 trials.
FREE DELIVERY
For shipping for all orders over $99.00
$170.00
Triple-agonist (GLP-1/GIP/glucagon) for multi-pathway metabolic regulation.
7 in stock
– Increases thermogenesis via glucagon receptor. – Enhances hepatic fat clearance. – Supports lean mass retention in calorie deficits.
Eli Lilly: Phase 2 trial showed 24% weight loss in 48 weeks. Link
PubChem CID: PubChem CID 171390338
PubChem Link:
Structure:
Structure Image
Summary:
Triple team burns fat, clears liver junk, and keeps muscles while dieting.
Select link below.
Store in a cool, dry place away from light.
Once Constituted, Please Refrigerate.
For long-term storage, freezing at -20°C is recommended to maintain integrity.
*Disclaimer*
Product Sku: SW-GLP-3RT-6 is strictly for laboratory use and should be handled with care. Adherence to proper storage and usage protocols is essential for maintaining its efficacy.
Notice: The products and information provided herein are intended solely for use in scientific and laboratory research. None of the products or information should be used for clinical, therapeutic, diagnostic, or any form of consumption by humans or animals. It is the responsibility of the user to comply with all local, state, federal, and international laws and regulations regarding the use and handling of these products.
Retatrutide balances incretin and glucagon signaling to boost energy expenditure and fat oxidation, achieving 17%+ weight loss in phase 2 trials.
| Size | 5mg |
|---|
Reviews
There are no reviews yet.